Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis-Reference-Cited by-同舟云学术

Novel approaches in IBD therapy: targeting the gut microbiota-bile acid axis

Published:2024-05-20 Issue:1 Volume:16 Page:
ISSN:1949-0976
Container-title:Gut Microbes
language:en
Short-container-title:Gut Microbes

Author:

Pan Yinping¹,Zhang Haojie¹,Li Minghui¹,He Tingjing¹,Guo Sihao¹,Zhu Liancai¹^ORCID,Tan Jun²,Wang Bochu¹

Affiliation:

1. Key Laboratory of Biorheological Science and Technology, Ministry of Education, College of Bioengineering, Chongqing University, Chongqing, PR China

2. Chongqing Key Laboratory of Medicinal Resources in the Three Gorges Reservoir Region, School of Biological & Chemical engineering, Chongqing University of Education, Chongqing, PR China

Funder

Science and Technology Research Program of Chongqing Education Commission of China

Chongqing Professional Talents Plan for Innovation and Entrepreneurship Demonstration Team

Graduate Research and Innovation Foundation of Chongqing, China

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/19490976.2024.2356284

Reference221 articles.

1. The gut microbiome

2. Role of metabolites derived from gut microbiota in inflammatory bowel disease

3. Bile Acids: Key Players in Inflammatory Bowel Diseases?

4. Targeting the gut microbiota for cancer therapy

5. Glycoursodeoxycholic acid regulates bile acids level and alters gut microbiota and glycolipid metabolism to attenuate diabetes

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring gut microbial metabolites as key players in inhibition of cancer progression: Mechanisms and therapeutic implications;Microbiological Research;2024-11

2. Yellow Teas Protect against DSS-Induced Ulcerative Colitis by Inhibiting TLR4/NF-κB/NLRP3 Inflammasome in Mice;Foods;2024-09-07

3. Intranasal Immunization of Pneumococcal pep27 Mutant Attenuates Allergic and Inflammatory Diseases by Upregulating Skin and Mucosal Tregs;Vaccines;2024-07-03

4. Ca2+-Dependent Processes of Innate Immunity in IBD;Cells;2024-06-21